Search Results for: neuroscience

Targeting Tools: Targeting the Dopamine Transporter

News Tools /

Advanced Targeting Systems announces the availability of two monoclonal antibodies to the dopamine transporter (DAT). These antibodies have become a standard for work on DAT and have already played a prominent role in the characterization of the dopamine transporter. The two antibodies are rat monoclonals, so they can be excellent for multiple staining protocols. Anti-DAT-NT, Cat. […]

Targeting Tools: Targeting the Dopamine Transporter Read More »

Apoptosis or Necrosis?

Q: Do targeted toxin-treated cells die by apoptosis? A: There are, allegedly, two ways for cells to die: by apoptosis or necrosis. According to Fiorenzo Stirpe (the discoverer of saporin), saporin-intoxicated cells die both ways, some by one, others by the other. There is good literature that states that cells die by apoptosis. Saporin and

Apoptosis or Necrosis? Read More »

Targeting Article: Targeted Toxins, Optogenetics, and the BRAIN Initiative

News Article /

Contributed by Brian J. Russell The newly invigorated BRAIN initiative (Brain Research through Advancing Innovative Neurotechnologies, also known as the Brain Activity Map Project) has placed a premium on understanding the role of each neuron within the human brain. This effort has been our focus for some time via our Targeted Toxin technology. From the

Targeting Article: Targeted Toxins, Optogenetics, and the BRAIN Initiative Read More »

Not the Right Stuff

Q: Are all lots of 192-Saporin (192-IgG-SAP, Cat. #IT-01) the same? A: There are variances from lot to lot, and Advanced Targeting Systems includes a cytotoxicity graph on the data sheet with each product comparing the current lot with previous lots. Chemicon International also sells immunotoxins, and used to distribute ATS products. However, since early

Not the Right Stuff Read More »

Cover Article: Targeted Lesion of Caudal Brainstem Catecholamine Neurons Reveals Their Role in Symptoms of Fatigue

News Article /

Contributed by Lisa E. Goehler and Ronald P.A. Gaykema Center for the Study of Complementary and Alternative Therapies, University of Virginia School of Nursing, Charlottesville, VA 22908 Fatigue, experienced as reduced motivation and motor activity, is common in acute and chronic disease, including heart disease, cancer and cancer chemotherapy. Fatigue is part of a constellation

Cover Article: Targeted Lesion of Caudal Brainstem Catecholamine Neurons Reveals Their Role in Symptoms of Fatigue Read More »

Targeting Tools: GAT1-SAP

News Tools /

GAT-1 is a sodium-coupled neurotransmitter transporter responsible for moving g-aminobutyric acid (GABA) across cell membranes. GABA is the predominant inhibitory neurotransmitter in the mammalian central nervous system. GAT-1 is widely distributed in both the central and peripheral nervous systems. GAT-1 and GABA are present in numerous neuronal pathways, some of which are implicated in epilepsy,

Targeting Tools: GAT1-SAP Read More »

CD11b Targeting Tools

Targeting Topics /

In a study produced by Ferrini et al. indicates that morphine-induced hyperalgesia, as neuropathic pain, is a pathological alteration of pain sensitivity whose expression is gated by spinal microglia. Targeting at any level, this microglia-to-neuron cascade is a valuable strategy to improve the use of morphine in chronic pain. Ferrini F, Trang T, Mattioli TA,

CD11b Targeting Tools Read More »

Targeting Article: SBIR Grant Funded: Selective Activation in Neuronal Populations

News Article /

ATS has been awarded a Phase I SBIR grant to develop a new line of products. Dr. Douglas Lappi is the Principal Investigator and Brian Russell is the Lead Scientist on the project. Molecules targeted towards cell surface markers have been used for years to identify specific cell types. It has been demonstrated over the

Targeting Article: SBIR Grant Funded: Selective Activation in Neuronal Populations Read More »

Search
Shopping Cart
Scroll to Top